| Date | Time | Source | Headline | Symbol | Company |
| 02/17/2012 | 6:01AM | Business Wire | Gilead Announces Data for Genotype 1 Null Responder Hepatitis C Patients Enrolled in ELECTRON Study | NASDAQ:GILD | Gilead Sciences Inc |
| 02/15/2012 | 4:00AM | Zacks | Weak Revenues Pull Down Actelion - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 02/14/2012 | 12:21PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/14/2012 | 9:18AM | Dow Jones News | US STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:GILD | Gilead Sciences Inc |
| 02/14/2012 | 6:45AM | Dow Jones News | US STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:GILD | Gilead Sciences Inc |
| 02/14/2012 | 6:17AM | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/13/2012 | 8:22PM | Dow Jones News | Gilead: FDA Fast Tracks Review Of HIV Drug Truvada | NASDAQ:GILD | Gilead Sciences Inc |
| 02/13/2012 | 7:25PM | Business Wire | U.S. FDA Grants Priority Review for Truvada® for Reducing the Risk of Acquiring HIV Infection | NASDAQ:GILD | Gilead Sciences Inc |
| 02/13/2012 | 1:10PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/10/2012 | 3:29PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/09/2012 | 4:30PM | Business Wire | Gilead Sciences to Present at Two Upcoming Investor Conferences | NASDAQ:GILD | Gilead Sciences Inc |
| 02/09/2012 | 4:17AM | Zacks | Forget Big Pharma, It Is Time For A Biotech ETF - ETF News And Commentary | NASDAQ:GILD | Gilead Sciences Inc |
| 02/08/2012 | 4:14PM | PR Newswire (US) | Investor Uprising IU25 Index Hits New High: Up 12% in 2012 | NASDAQ:GILD | Gilead Sciences Inc |
| 02/08/2012 | 10:36AM | Zacks | Generic Challenge for UTHR's Remodulin - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 02/08/2012 | 9:31AM | PR Newswire (US) | Critical Alerts For Disney, Gilead Sciences, Discover, Sunoco, and LG Display Released By Seven Summits Research | NASDAQ:GILD | Gilead Sciences Inc |
| 02/06/2012 | 9:00AM | Marketwired | Perception, Opportunity in Volatility - Research & Analysis on Zynga Inc and Gilead Sciences, Inc. | NASDAQ:GILD | Gilead Sciences Inc |
| 02/06/2012 | 4:06AM | Zacks | Company News for February 6, 2012 - Corporate Summary | NASDAQ:GILD | Gilead Sciences Inc |
| 02/03/2012 | 12:36PM | Dow Jones News | UPDATE: Idenix Says FDA Partial Hold On Hepatitis C Drug Lifted | NASDAQ:GILD | Gilead Sciences Inc |
| 02/03/2012 | 9:15AM | Marketwired | 4 Active Stocks on Traders Radar Screens for 02/03/12: GFMD, ZOLT, GILD, BAC | NASDAQ:GILD | Gilead Sciences Inc |
| 02/03/2012 | 4:00AM | Zacks | Gilead Misses EPS Ests, Sales Up - Analyst Blog | NASDAQ:GILD | Gilead Sciences Inc |
| 02/02/2012 | 5:20PM | Dow Jones News | Gilead's 4Q Profit Rises 5.7% As Product Sales Continue To Climb | NASDAQ:GILD | Gilead Sciences Inc |
| 02/02/2012 | 4:16PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 02/02/2012 | 4:05PM | Business Wire | Gilead Sciences Announces Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:GILD | Gilead Sciences Inc |
| 02/01/2012 | 2:21PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/30/2012 | 7:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/30/2012 | 7:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/30/2012 | 6:58PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/30/2012 | 6:48PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/30/2012 | 6:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:GILD | Gilead Sciences Inc |
| 01/26/2012 | 4:30PM | Business Wire | Gilead Sciences to Release Fourth Quarter and Year End 2011 Financial Results on Thursday, February 2, 2012 | NASDAQ:GILD | Gilead Sciences Inc |